Company
DermaSensor
Innovative assessment for skin cancer risk
Also known as DermaSensor, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Founded
- 2009
- Employees
- 17 employees (Form C/A)Source (opens in a new tab)
- Customers
- healthcare institutions
- Legal name
- DermaSensor, Inc.
- dermasensor.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
The DermaSensor device is the only FDA cleared, automated solution for skin cancer detection. The non-invasive, AI-powered device improves the early detection of cancerous lesions.
Funding snapshot
- Total raised
- $29.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Reg cf crowdfunding, $5M2026-09-09
Funding rounds
- Reg cf crowdfunding
- $5M2026-09-09, Company stated
- Reg cf crowdfunding
- $1.2M2026-09-08, SEC form C
- Reg cf crowdfunding
- $1.2M2026-07-21, SEC form C
- Reg cf crowdfunding
- $1.2M2026-07-16, SEC form C
- Round, 2025
- $16M2025-10-02, Company stated
- Round, 2024
- $8.9M2024-11-15, SEC form D sold, 41 investors
- Round, 2021
- $8.5M2021-12-03, SEC form D sold, 168 investors
- Round, 2020
- $5.9M2020-02-27, SEC form D sold, 97 investors
- Round, 2018
- $5.8M2018-11-01, SEC form D sold, 23 investors
Products
- Hardware
- DermaSensor device
Loading relationship preview